PMID 10569624
Protease inhibitor co-formulations showed promise in preclinical models but raised safety concerns about chronic inhibition of digestive enzymes and were often ineffective against the full spectrum of proteases encountered along the gastrointestinal tract
Improvement in Liver Enzymes and Fat Reduction A significant benefit observed in NAFLD patients is reduced ALT levels, a marker of liver inflammation
Biomarkers including fasting insulin, insulin resistance (HOMA-IR), and inflammatory markers (CRP) help providers understand whether plateau reflects metabolic adaptation, insufficient medication dosage, or lifestyle drift
At the federal level, the Trump administration decided not to proceed with a Biden administration proposal to allow Medicare and require Medicaid to cover obesity drugs but recently launched their own obesity drug coverage initiatives to reduce costs and increase access (see Box 1)
its blockade increases serotonin release Promotes neurogenesis : TREK-1 knockout mice show increased hippocampal neurogenesis, and PE-22-28 recapitulates this effect pharmacologically within 4 days of treatment Induces synaptogenesis : TREK-1 blockade promotes dendritic growth and synaptic connection formation PE-22-28 inhibits TREK-1 with an IC50 of 0.12 nM, making it approximately 300-500 times more potent than spadin